616 related articles for article (PubMed ID: 28456755)
1. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
Grogan M; Dispenzieri A; Gertz MA
Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
[TBL] [Abstract][Full Text] [Related]
2. Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B
Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674
[TBL] [Abstract][Full Text] [Related]
3. Harnessing Cardiac Regeneration as a Potential Therapeutic Strategy for AL Cardiac Amyloidosis.
Joshi S; Evangelisti A; Liao R; Alexander KM
Curr Cardiol Rep; 2020 Jan; 22(1):1. PubMed ID: 31932992
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the management of AL Amyloidosis.
Kastritis E; Dimopoulos MA
Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
[TBL] [Abstract][Full Text] [Related]
5. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
6. Cardiac amyloidosis: approaches to diagnosis and management.
Desai HV; Aronow WS; Peterson SJ; Frishman WH
Cardiol Rev; 2010; 18(1):1-11. PubMed ID: 20010333
[TBL] [Abstract][Full Text] [Related]
7. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
9. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.
Ng B; Connors LH; Davidoff R; Skinner M; Falk RH
Arch Intern Med; 2005 Jun; 165(12):1425-9. PubMed ID: 15983293
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin light chain amyloidosis.
Merlini G; Comenzo RL; Seldin DC; Wechalekar A; Gertz MA
Expert Rev Hematol; 2014 Feb; 7(1):143-56. PubMed ID: 24350907
[TBL] [Abstract][Full Text] [Related]
11. Cardiac amyloidosis: an approach to diagnosis and management.
Halwani O; Delgado DH
Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):1007-13. PubMed ID: 20602561
[TBL] [Abstract][Full Text] [Related]
12. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.
Brenner DA; Jain M; Pimentel DR; Wang B; Connors LH; Skinner M; Apstein CS; Liao R
Circ Res; 2004 Apr; 94(8):1008-10. PubMed ID: 15044325
[TBL] [Abstract][Full Text] [Related]
13. Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis.
Swiger KJ; Friedman EA; Brittain EL; Tomasek KA; Huang S; Su YR; Sawyer DB; Lenihan DJ
Amyloid; 2016 Dec; 23(4):242-248. PubMed ID: 27809600
[TBL] [Abstract][Full Text] [Related]
14. Severe heart failure from light chain cardiomyopathy (cardiac amyloidosis).
Hofer JF; Wimmer G
Z Kardiol; 2003 Jan; 92(1):90-5. PubMed ID: 12545307
[TBL] [Abstract][Full Text] [Related]
15. Natural history and therapy of AL cardiac amyloidosis.
Grogan M; Dispenzieri A
Heart Fail Rev; 2015 Mar; 20(2):155-62. PubMed ID: 25447844
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias.
Kourelis TV; Kumar SK; Go RS; Kapoor P; Kyle RA; Buadi FK; Gertz MA; Lacy MQ; Hayman SR; Leung N; Dingli D; Lust JA; Lin Y; Zeldenrust SR; Rajkumar SV; Dispenzieri A
Am J Hematol; 2014 Nov; 89(11):1051-4. PubMed ID: 25111004
[TBL] [Abstract][Full Text] [Related]
17. Future directions in the clinical management of amyloid light-chain amyloidosis.
Haider S; Ahmad N; Anaissie E; Driscoll JJ
Leuk Lymphoma; 2014 Oct; 55(10):2241-51. PubMed ID: 24359238
[TBL] [Abstract][Full Text] [Related]
18. Amyloidosis in Heart Failure.
Ihne S; Morbach C; Obici L; Palladini G; Störk S
Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
[TBL] [Abstract][Full Text] [Related]
19. Unusual Case of Cardiac Amyloidosis Preceded by a Twenty-year History of Dilated Cardiomyopathy and Heart Failure.
Shimada S; Maekura S; Ino H; Matsuura M; Masunaga N; Matsumoto T; Hama J
Intern Med; 2016; 55(9):1109-15. PubMed ID: 27150863
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]